September 15th 2021
Paris, September 15, 2021 – 7:00 am CEST
CARMAT (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative to people suffering from end-stage biventricular heart failure, today reports its results for the first half of the year to June 30, 2021[2] and issues an update on its latest progress and main strategic objectives.
Stéphane Piat, Chief Executive Officer of CARMAT, commented: “Following the granting of CE marking in December 2020, CARMAT dedicated most of its resources to preparing the commercial launch in Europe, initiating the EFS in the US and strengthening its supply chain. Despite the constraints associated with the COVID-19 pandemic, CARMAT achieved key milestones: since July, 6 patients in leading German and Italian hospitals did benefit from Aeson®, the world’s first physiological artificial heart, in a commercial setting. CARMAT also successfully completed the enrollment of the first cohort of 3 patients in the EFS study, with some of the largest and renowned American cardiology centers such as Duke University Hospital, paving the way to the evaluation of our device in the US, the world’s largest medical device market. The very positive feedback regarding the implantations of Aeson® in both commercial and clinical trials settings is further demonstrating our confidence that our device represents a valid alternative to heart transplants. We anticipate that around a dozen European centers, primarily in Germany, will be commercially active by the end of 2021. In order to support this momentum, CARMAT has also been working on ramping up its production activities, which should allow the company to manufacture Aeson® prostheses at an increasing pace in order to appropriately supply hospitals that would like to offer our unique technology to their patients”.
[1] Early Feasibility Study
[2] First-half results were approved by the Board on September 13, 2021 and have been the subject of a limited review by the statutory auditors. The 2021 half-year financial report was published today and is available on the Company’s website.